PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES- A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS
Abstract
Authors
E. Keystone R. Fleischmann C. Han J.S. Smolen P. Emery M. Genovese T. Gathany M. Doyle E. Hsia